Assisted reproductive technologies (ART), such as in vitro fertilisation (IVF), play an increasing significant
role in the treatment of infertility, with almost one child in every Australian class room now conceived using
such technologies. Due to the higher incidence of twins and triplets after ART treatment, these children have
significantly poorer outcomes than other children. Through a series of economic analyses, this project will
determine the most cost-effective, equitable and safe way of funding ART in Australia, including an assessment of the effect of recent changes to Medicare funding. The project will also estimate the contribution that ART makes to society in terms of economic returns and the societal value of ART children.
IVF Australia Pty Limited - ARC Linkage Project Industry Partner Contribution|LP100200165